Allergan Competitive Intelligence & Landscape
allergan.co.nz ·
Overview
Allergan Overview
Allergan Aesthetics New Zealand offers a diverse portfolio of aesthetic products. Key offerings include BOTOX®, various JUVÉDERM® dermal fillers such as VOLITE™, VOLBELLA® with Lidocaine, VOLIFT® with Lidocaine, VOLUMA® with Lidocaine, VOLUX™, ULTRA XC, and ULTRA PLUS XC. They also provide SKINVIVE® by JUVEDERM®, HArmonyCa®, and breast aesthetics products like BRST™ Natrelle® CoolSculpting® REVOLVE™ System and BIOCELL® [https://www.allergan.co.nz/].
The target market for Allergan Aesthetics New Zealand includes medical professionals and providers in the aesthetic medicine field, as the company emphasizes supporting their customers' practices and careers. While specific founding year, headquarters, and company size for the New Zealand entity are not detailed on the homepage, its affiliation with AbbVie Inc. indicates a connection to a global pharmaceutical company [https://www.allergan.co.nz/].
Allergan Weekly Intel Updates
Receive weekly intel updates about Allergan straight to your inbox.
Competitors
Allergan Competitors
One of the primary direct competitors to Allergan Aesthetics is Galderma.
Galderma is a key player in the aesthetics industry, often cited alongside Allergan Aesthetics and Merz Aesthetics as one of the top three.
Galderma offers a distinct range of aesthetic products that compete directly with Allergan Aesthetics's offerings, particularly in the botulinum toxin and dermal filler segments [source]. While Allergan Aesthetics benefits from strong brand loyalty and higher pricing for Botox®, Galderma challenges its market dominance through product innovation and competitive strategies [source].
Another significant direct competitor is Merz Aesthetics. Like Galderma, Merz Aesthetics is recognized as one of the top three leaders in the aesthetics industry, offering a portfolio of aesthetic pharmaceuticals that compete with Allergan Aesthetics's offerings [source].
Merz Aesthetics's products, which include their own botulinum toxin and filler lines, have challenged Allergan Aesthetics's long-standing market leadership [source]. The company's focus on distinct strengths and competitive strategies helps it vie for market share against Allergan Aesthetics.
In the broader healthcare and pharmaceutical sector, companies like Bausch & Lomb emerge as indirect competitors. While Bausch & Lomb manufactures surgical and vision care products [source], they are listed among Allergan's top competitors. This suggests that while their core focus may differ, there might be overlapping product categories or market segments where they indirectly compete, or perhaps their expansive R&D capabilities and market presence pose a competitive threat.
Pharmaceutical giants such as Pfizer, Johnson & Johnson, and Roche also represent indirect, yet formidable, competition. These multinational corporations have extensive pharmaceutical research capabilities and robust pipelines across diverse therapeutic areas, including oncology, immunology, and CNS disorders [source]. Their substantial investments in innovation and market expansion strategies across various sectors mean they command significant market share and resources, indirectly competing with Allergan Aesthetics for research talent, investment, and overall healthcare market influence, even if their direct aesthetic product offerings are not as pronounced.
Sources
Top Allergan Alternatives, Competitors - CB Insights
cbinsights.com
Top Allergan Competitors and Alternatives | Craft.co
craft.co
Who are the main competitors of Allergan? - Patsnap Synapse
synapse.patsnap.com
Allergan Competitors and Alternatives - Owler
owler.com
The Complete Guide To Allergan® Aesthetics Competitors
pipelinemedical.com
Allergan's Competitors, Revenue, Number of Employees ... - Owler
owler.com
Top 3 Market Competitors in the Global Botulinum Toxin A Market
idataresearch.com
Allergan Competitors | Comparably
comparably.com
Allergan Ltd Peers & Key Competitors - GlobalData
globaldata.com
Allergan Aesthetics, an AbbVie Company
allerganaesthetics.com
Product & Pricing
Allergan Product and Pricing Intelligence
The company's product portfolio includes well-known brands such as BOTOX®, JUVÉDERM® (including various formulations like VOLITE™, VOLBELLA®, VOLIFT®, VOLUMA®, VOLUX™, ULTRA XC, and ULTRA PLUS XC), and SKINVIVE® by JUVEDERM®. They also offer HArmonyCa®, BRST™ Natrelle®, CoolSculpting®, REVOLVE™ System, and BIOCELL® products. As an AbbVie Company, their focus is on providing these products to medical professionals, emphasizing patient care, education, and customer support.
Since direct pricing information is not available on their public-facing website, it is likely that product pricing for Allergan Aesthetics New Zealand is handled through direct consultation with providers or sales representatives. The website does not indicate any recent pricing changes or specific pricing models for their aesthetic medicine solutions, suggesting a B2B model where prices are negotiated or provided directly to qualified medical practices.
Ad Campaigns
Allergan Ad Campaigns
See the live ads Allergan is running across Google, Meta, and LinkedIn — the creative, messaging, and platforms behind every campaign, updated automatically by ForesightIQ.
See of Allergan's ads
Browse the live creative across Google, Meta & LinkedIn in the ad library
Hiring & Layoffs
Allergan Hiring and Layoffs
The company's focus on "the products and technologies that drive the advancement of aesthetic medicine" [https://www.allergan.co.nz/] implies a strategic interest in roles related to research, development, sales, marketing, and medical education within this specialized field. Their commitment to "patient-care and education and support of our customers" suggests a need for professionals who can uphold these values.
There is no public information available on allergan.co.nz regarding recent layoffs. The consistent presence of career-related pages suggests a stable, if not growing, workforce to support its mission of empowering possibilities in aesthetic medicine. The website's emphasis on advancement and innovation further hints at a hiring strategy focused on attracting skilled individuals who can contribute to their product development and market presence.
Leadership
Allergan Management and Leadership Team
The Allergan Aesthetics website in New Zealand, being an AbbVie Company, indicates that its operational structure and leadership may be integrated within the broader AbbVie corporate framework. While the site emphasizes its purpose and values, it does not provide individual names or roles of the local New Zealand leadership team.
The sitemap for Allergan (allergan.co.nz/en-nz/sitemap) includes sections such as "About" and "Careers," with a specific page for "Working at Allergan." These sections typically provide insights into the company's culture and opportunities but do not publicly list the detailed leadership structure or specific individuals at the executive level for the New Zealand operations. The site also links to a "Corporate Website" (http://www.allergan.com), which might contain global corporate leadership information, but this would not specifically detail the New Zealand management team.
Financials
Allergan Financial Performance, Fundraising, M&A
As a division of AbbVie, Allergan Aesthetics benefits from the resources and financial backing of a global pharmaceutical company. The website (allergan.co.nz) focuses on promoting its aesthetic products like BOTOX®, JUVÉDERM®, and CoolSculpting®, and does not disclose independent financial statements or investment rounds for the New Zealand operation.
The sitemap for allergan.co.nz includes links to abbvie.co.nz and abbvie.com, reinforcing that financial and corporate information for Allergan Aesthetics New Zealand would likely be found through AbbVie's corporate reporting. This structure means that fundraising and M&A activities would typically be conducted at the AbbVie corporate level, rather than by the individual New Zealand domain. Therefore, the financial health of allergan.co.nz is intrinsically linked to the overall financial performance and strategic decisions of AbbVie Inc.
Partnerships
Allergan Partnerships, Clients and Vendors
Allergan Aesthetics is committed to supporting its customers, placing emphasis on patient care and education. While specific enterprise clients are not explicitly named on their website, their business model suggests a client base of medical professionals and aesthetic practitioners who utilize their products, such as BOTOX®, JUVÉDERM®, and CoolSculpting®.
While the website does not detail technology integrations with external vendors, the company's commitment to creating products and technologies for aesthetic medicine implies internal technological development. The website also provides links to global sites, suggesting connections to Allergan's international network, facilitating a wider ecosystem for their products and services.
Their commitment to patient care and customer support forms the foundation of their client relationships. The company's website includes sections for "For Providers" and "Medical Education," which highlight their dedication to supporting the practices and ongoing professional development of their clients. They also offer resources like a product list and information on breast warranties for certain products.
Events
Allergan Event Participations
The company's structure, as evidenced by sections like "Medical Education" and "For Providers: Your Practice. Our Purpose," indicates a strong emphasis on professional development and engagement within the aesthetic community. Such sections typically facilitate communication about educational initiatives, which often include participation in and hosting of various events for healthcare professionals. Although specific events are not named, the foundational elements for engaging with providers and advancing aesthetic medicine are clearly present.
Allergan Aesthetics New Zealand prioritizes scientific backing in its product development and technologies. Their dedication to supporting the lives, businesses, and careers of those they serve implies active engagement with their customer base, which can encompass various event formats. While a direct list of events is not available, the company's overall mission and structure strongly suggest a robust program of participation and possibly sponsorship in events relevant to the aesthetics industry in New Zealand.
Frequently Asked Questions
What is Allergan Aesthetics New Zealand's strategic focus in the aesthetic medicine market?
Allergan Aesthetics New Zealand, an AbbVie company, strategically focuses on advancing aesthetic medicine through science-backed products and technologies. Their mission is centered on patient care, education, and robust customer support, ensuring their offerings like BOTOX® and JUVÉDERM® fillers empower possibilities for both patients and medical professionals.
What does the presence of 'Careers' and 'Working at Allergan' sections on Allergan Aesthetics New Zealand's sitemap indicate about its workforce strategy?
The consistent presence of 'Careers' and 'Working at Allergan' sections on Allergan Aesthetics New Zealand's sitemap indicates an ongoing and structured need for talent. This suggests a stable, if not growing, workforce to support its mission in aesthetic medicine, focusing on attracting skilled individuals for roles in research, development, sales, marketing, and medical education.
How does Allergan Aesthetics New Zealand's affiliation with AbbVie Inc. influence its financial operations and reporting?
Allergan Aesthetics New Zealand's affiliation with AbbVie Inc. means it operates under the financial umbrella of its parent company. Specific financial performance, fundraising, and M&A activities for the New Zealand entity are not disclosed independently; rather, these would be managed and reported at the AbbVie corporate level, linking Allergan Aesthetics New Zealand's financial health to AbbVie Inc.'s overall performance.
What is Allergan Aesthetics New Zealand's primary target market for its products?
Allergan Aesthetics New Zealand primarily targets medical professionals and providers in the aesthetic medicine field. The company emphasizes supporting their customers' practices and careers, indicating a business-to-business (B2B) model where products like BOTOX® and JUVÉDERM® are supplied to clinics and practitioners.
What implications does the lack of explicit leadership details on Allergan Aesthetics New Zealand's website have for understanding its local management structure?
The lack of explicit leadership details for Allergan Aesthetics New Zealand on its website suggests that its operational structure and leadership are likely integrated within the broader AbbVie corporate framework. While the site focuses on products and values, specific local management roles or individuals are not publicly listed, implying central governance from AbbVie.
Who are Allergan Aesthetics New Zealand's primary direct competitors in the aesthetic medicine market?
Allergan Aesthetics New Zealand's primary direct competitors in the aesthetic medicine market are Galderma and Merz Aesthetics. Both companies offer rival products in the botulinum toxin and dermal filler segments, challenging Allergan Aesthetics's market dominance through product innovation and competitive strategies.
How does Allergan Aesthetics New Zealand's product portfolio differentiate it in the aesthetic medicine market?
Allergan Aesthetics New Zealand differentiates itself with a diverse portfolio of established aesthetic products, including widely recognized brands like BOTOX®, various JUVÉDERM® dermal fillers (e.g., VOLITE™, VOLBELLA®), SKINVIVE® by JUVEDERM®, HArmonyCa®, BRST™ Natrelle®, CoolSculpting®, REVOLVE™ System, and BIOCELL®.
What kind of alternatives might medical professionals consider instead of Allergan Aesthetics New Zealand's offerings?
Medical professionals might consider alternatives such as Galderma, which offers a broader focus on dermatological skincare alongside injectables; Merz Aesthetics®, a direct competitor with similar product categories; Revance, particularly for biosimilar neurotoxin treatments potentially offering cost-effective options; and Pluryal, a European-based company specializing in dermal fillers and mesotherapy with a distinct heritage.
What does Allergan Aesthetics New Zealand's emphasis on 'Medical Education' and 'For Providers' sections suggest about its engagement strategy?
Allergan Aesthetics New Zealand's emphasis on 'Medical Education' and 'For Providers' sections suggests a strong engagement strategy focused on professional development and support for its client base of medical professionals. This indicates a commitment to education, industry gatherings, and fostering robust relationships with practitioners who use their products.
Why is specific pricing information for Allergan Aesthetics New Zealand's products not publicly available on its website?
Specific pricing information for Allergan Aesthetics New Zealand's products is not publicly available on its website because the company likely operates on a business-to-business (B2B) model. Product pricing is handled through direct consultation with providers or sales representatives, suggesting negotiated rates or direct provision of prices to qualified medical practices rather than a public price list.
Powered by ForesightIQ · Competitive intelligence from digital exhaust